| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |